【腦部】《RebrAIn》旗下深層腦部刺激(DBS) 「OptimMRI」獲第二次FDA 510(k)許可

 【腦部】《RebrAIn》旗下深層腦部刺激(DBS) 「OptimMRI」獲第二次FDA 510(k)許可

 文章出處  

Businesswire 

 

 原文標題  

RebrAIn Receives Second FDA 510(k) Clearance to Optimize Targeting in Stereotactic and Functional Neurosurgery for Both Deep Brain Stimulation and Lesioning Techniques (MRgFUS and Radiosurgery) 

 

 Twitter  

https://x.com/aimedadviser/status/1830382312112148649 

 

 文章序號  

6201 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.